—Mkt Cap: —P/E: —
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value44.94B USD
Revenue (TTM)6.30B USD
Gross Profit4.73B USD
Net Income (TTM)1.07B USD
Revenue/Share10.81 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees16.0K
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISINUS28176E1082
Valuation
P/E (Trailing)—
P/E (Forward)24.74
PEG2.00
EV/EBITDA23.61
EV/Revenue7.13
P/S7.60
P/B4.65
EPS (TTM)1.85
EPS (Forward)3.36
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin78.01%
Oper. Margin31.22%
EBITDA Margin30.20%
Profit Margin17.69%
ROE10.38%
ROA7.84%
Growth
Revenue Growth16.70%
Earnings Growth8.20%
Cash Flow & Leverage
Operating CF1.60B USD
CapEx (TTM)260.20M USD
FCF Margin14.31%
FCF Yield—
Net Debt-2.97B USD
Net Debt/EBITDA-1.56
Balance Sheet
Debt/Equity0.07
Current Ratio4.42
Quick Ratio3.30
Book Value/Sh17.90 USD
Cash/Share6.376 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3:1
Split DateJun 1, 2020
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)97.15 USD
Target Range84.00 USD – 110.00 USD
# Analysts27
Ownership
Shares Out.575.80M
Float573.95M
Insiders0.18%
Institutions94.28%
Short Interest
Short Ratio1.9d
Short % Float2.08%
Short % Out.1.83%
Shares Short10.54M
Short (prev mo.)9.97M
Technical
SMA 5081.43 USD
SMA 20081.29 USD
Beta0.87
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)4.37M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—